Abiopharma

🔍 Ervin Jeffrey S (Executive)

Company: Allarity Therapeutics, Inc. (ALLR)

Report Date: 2026-01-28

Detailed Transactions and Holdings:

• Acquired 150,000 shares of Common Stock (Direct)
  Date: 2026-01-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.